» Articles » PMID: 5351864

Locomotor Activity and Anorexogenic Action

Overview
Specialty Pharmacology
Date 1969 Jan 1
PMID 5351864
Citations 15
Authors
Affiliations
Soon will be listed here.
Citing Articles

Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption.

Slezak J, Desai R, Katz J Behav Pharmacol. 2016; 28(1):74-82.

PMID: 27926573 PMC: 5233561. DOI: 10.1097/FBP.0000000000000278.


Addiction potential of phentermine prescribed during long-term treatment of obesity.

Hendricks E, Srisurapanont M, Schmidt S, Haggard M, Souter S, Mitchell C Int J Obes (Lond). 2013; 38(2):292-8.

PMID: 23736363 DOI: 10.1038/ijo.2013.74.


Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.

Wright F, Rodgers R Psychopharmacology (Berl). 2013; 228(2):291-307.

PMID: 23455599 DOI: 10.1007/s00213-013-3036-6.


A high-throughput fluorescence-based assay system for appetite-regulating gene and drug screening.

Shimada Y, Hirano M, Nishimura Y, Tanaka T PLoS One. 2013; 7(12):e52549.

PMID: 23300705 PMC: 3530442. DOI: 10.1371/journal.pone.0052549.


Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

de la Torre R, Farre M, Navarro M, Pacifici R, Zuccaro P, Pichini S Clin Pharmacokinet. 2004; 43(3):157-85.

PMID: 14871155 DOI: 10.2165/00003088-200443030-00002.


References
1.
Melander B . Psychopharmacodynamic effects of diethylpropion (Tylinal). Acta Pharmacol Toxicol (Copenh). 1960; 17:182-90. DOI: 10.1111/j.1600-0773.1960.tb01242.x. View

2.
Grossman S . Direct adrenergic and cholinergic stimulation of hypothalamic mechanisms. Am J Physiol. 1962; 202:872-82. DOI: 10.1152/ajplegacy.1962.202.5.872. View

3.
Janssen P, NIEMEGEERS C, SCHELLEKENS K . IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS. Arzneimittelforschung. 1965; 15:104-17. View

4.
VAN ROSSUMJ , HURKMANS A . MECHANISM OF ACTION OF PSYCHOMOTOR STIMULANT DRUGS. SIGNIFICANCE OF DOPAMINE IN LOCOMOTOR STIMULANT ACTION. Int J Neuropharmacol. 1964; 3:227-39. DOI: 10.1016/0028-3908(64)90012-7. View

5.
Hornykiewicz O . Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966; 18(2):925-64. View